Disease Activity
78DAS
+12 vs last visit
Visual Acuity RE
58ETDRS
−4 letters (3m)
Central Retinal Thickness
312µm
+31µm vs last
Current T&E Interval
6weeks
Shortened from 8wk
Total Injections
18lifetime
3 this year
AI Recommendation
Updated 21:11Inject Today
Faricimab · RE · Visit #18
94%
confidence
Key Drivers
Active SRF detected92%
IRF present (+0.8µL)88%
DAS score 78 (High)95%
VA declining (−4 letters)71%
Risk Assessment
Recurrence Risk (4wk)87%
Vision Loss Risk (12m)34%
GA Progression Risk12%
Fellow Eye Conversion18%
Systemic Flags
HypertensionControlled
Type 2 DiabetesHbA1c 7.2%
AnticoagulationWarfarin